— Know what they know.
Not Investment Advice

TIL NASDAQ

Instil Bio, Inc.
1W: +0.7% 1M: -6.1% 3M: -6.5% YTD: -35.9% 1Y: -62.2% 3Y: -12.4% 5Y: -98.4%
$7.22
-0.01 (-0.21%)
 
Weekly Expected Move ±3.8%
$7 $7 $7 $7 $8
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $49.0M mcap · 4M float · 0.368% daily turnover · Short 52% of daily vol

Balance Sheet Trends

Total Assets
$204M -22.8% ▼
5Y CAGR: -8.6%
Total Liabilities
$90M -4.8% ▼
5Y CAGR: +27.5%
Shareholders Equity
$114M -32.8% ▼
5Y CAGR: -17.2%
Cash & Investments
$76M -32.8% ▼
5Y CAGR: -20.6%
Total Debt
$85M -2.0% ▼
Net Debt
$79M +0.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$38M$44M$9M$9M$7M
Short-Term Investments$417M$217M$141M$105M$69M
Cash & ST Investments$454M$261M$150M$113M$76M
Net Receivables$0$0$0$0$848K
Inventory$0$0$0$0$0
Other Current Assets$0$8M$2M$2M$114M
Total Current Assets$464M$269M$161M$124M$191M
Property, Plant & Equip.$122M$209M$141M$130M$364K
Goodwill & Intangibles$16M$0$0$0$0
Long-Term Investments$0$0$23M$0$0
Other Non-Current Assets$8M$3M$639K$9M$12M
Total Non-Current Assets$146M$213M$165M$139M$12M
Total Assets$610M$482M$326M$264M$204M
— Liabilities —
Accounts Payable$6M$2M$1M$659K$779K
Short-Term Debt$0$0$0$0$372K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$14M$4M$1M$2M$4M
Total Current Liabilities$41M$33M$11M$8M$5M
Long-Term Debt$0$72M$81M$84M$85M
Other Non-Current Liab.$11M$8M$5M$1M$8K
Total Non-Current Liabilities$13M$86M$89M$86M$85M
Total Liabilities$55M$119M$100M$94M$90M
— Equity —
Common Stock$0$0$0$0$0
Retained Earnings-$202M-$425M-$581M-$655M-$726M
Accumulated OCI-$87K-$493K-$348K-$228K-$583K
Total Stockholders Equity$555M$364M$226M$169M$114M
Total Liabilities & Equity$610M$482M$326M$264M$204M
— Key Metrics —
Total Debt$0$80M$86M$87M$85M
Net Debt-$38M$36M$77M$78M$79M
Total Investments$417M$217M$164M$105M$69M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms